Skip to main content

Table 1 Available information on different outcomes among selected studies on anti-CGRP monoclonal antibodies in chronic migraine

From: CGRP-targeted medication in chronic migraine - systematic review

Study

Reduction in MHDs

Reduction in MMDs

Reduction on HIT-6

Reduction on monthly pain medication intake

Follow-up (months)

3

6

12

3

6

12

3

6

12

3

6

12

[32]

   

X

X

X

   

X

X

X

[23]

X

X

    

X

  

X

X

 

[24]

            

[25]

X

X

    

X

X

    

[26]

X

X

 

X

X

 

X

X

 

X

X

 

[21]

   

X

 

X

      

[18]

X

  

X

  

X

     

[19]

   

X

        

[22]

   

X

  

X

  

X

  

[20]

X

 

X

X

 

X

      
  1. HIT-6 – Headache Impact Test 6; MHDs - monthly headache days; MMDs - monthly migraine days
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us